MORF Articles, Morphic Holding Inc.

WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of oral...

WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of oral...

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (https://aftlaw.com/), a nationally recognized law firm that f...

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company developing a new generation of...

WALTHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of or...

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to d...

SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to d...

SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding, Inc. (NASDAQ:...

SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to d...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Por...